FDA OKs Merck drug that prevents infection post-stem cell transplant – Business Insider
Medscape |
FDA OKs Merck drug that prevents infection post-stem cell transplant
Business Insider (Reuters) – Merck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. Merck said the drug, which is expected to be … Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection FDA Approves Prevymis to Prevent CMV Among Stem Cell Transplant Patients |
